Groowe Groowe / Newsroom / ALNY
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

ALNY News

Alnylam Pharmaceuticals, Inc.

$73 Billion Non-Opioid Therapeutics Industry Assessment, 2032 Featuring AbbVie, GlaxoSmithKline, Acorda Therapeutics, Allay Therapeutics, Alnylam Pharmaceuticals and Other Key Players

globenewswire.com
ABBV GSK ALNY

Astellas to Present New Clinical Data Across Its Gastrointestinal Cancers Portfolio at 2026 ASCO GI Cancers Symposium

prnewswire.com
ALNY

Elevance Health Board Welcomes Amy Schulman as New Director, Reflecting Ongoing Commitment to Governance Excellence

businesswire.com
ELV PFE ALNY

Global Medical Device Contract Manufacturing Market is Predicted to Cross the USD 190 Billion Mark by 2032, Owing to the Rising Demand for Advanced Healthcare Solutions | DelveInsight

globenewswire.com
TMO PFE AMGN BMY MRK DHR ABBV GOOG MSFT JNJ MDT BSX SYK EW ISRG EMR BIOX EXAS QRVO TER ADI TXN ON INTC NVDA AMD HPQ DELL IBM GE FISV ADP PAYX NOW CRM ORCL SAP ADSK CDNS SNPS AMAT INFY HPE LOGI ATHM BIIB GILD REGN VRTX AMRN AZN LLY NVS CRSP EDIT NTLA ALNY INCY XRAY COO MASI IRTC MRNA EMB ADMA ICUI HOLX LH DGX RDNT EVTC AFYA CHKP DDOG SMCI ALGN THRY PTC MCHP NXPI QCOM SWKS MU WDC STX

Cell and Gene Therapy Market Size to Worth USD 232.22 Billion, Rising at 24% CAGR by 2035

globenewswire.com
AMGN BIIB NVS PFE REGN NTLA ALNY

Hemophilia A Market to Exhibit Growth at a CAGR of 2.9% During the Forecast Period (2025-2034) Owing to the Rising Hemophilia Prevalence, Strong Uptake of New Drugs, and Emergence of High-cost Gene Therapies | DelveInsight

prnewswire.com
NVO ULTX SGMO PFE BMN SNY CHGC RHHBY ALNY BIIB BAY TSEM CSL HEMA LFB OCT SOBI ASC

Sickle Cell Disease Market is Predicted to Exhibit Remarkable Growth at a CAGR of 22.1% During the Forecast Period (2025–2034) Across 6MM, Owing to the Increasing Prevalence, Awareness, and Advancements in Gene Therapies | DelveInsight

globenewswire.com
PFE NVO AGIO FCRX BLUE ALXN Takeda REGN BEAM EDIT SANG SRPT CRSP XENE GILD AMGN BMRA BIIB ACRX AZN SNY ROCHE CSL SANA INVO VRTX ABBV LLY JNJ MRK BMY MDCO PTLA RHHBY BCLI CELG NBIX ALNY SPRC ACST ADPT AMTX APLS ARNA ATRC AVEO AXSM BPMC CDMO CLVS CNCE CRBP CTIC CYTK DFFN DOCU DRNA DTIL EARS EBAY ECHO EGRX ENDP ENZ EPZM ESRX EXAS FGEN FMI FRPT FTNT GALT GENE GNTX GRFS GSK HALO HAYW HBMD HGEN HLTH HPE HTGM ICPT IDXX ILMN IMCR IMNX INCY IND INTC INTU IOVA IRTC ISRG ITCI JAZZ KDP KHC KODK LAKE LULU LPTX LSCC LX LYFT MARA MCRB MDLZ MED MELI MGM MITK MLNX MNST MRVL MSFT MTCH MU MXIM MYL NCLH NDSN NET NEWM NFLX NKE NOC NOV NTES NVDA NXPI OBLN OC ODFL OLED OMER ON ONDK ORCL ORGN OSUR OTIS OXBR PACB PANW PAYX PCAR PCG PDD PEGA PEP PGR PGRD PHG PI PINS PLAB PLAY PLRX PM PNRA PPC PPD PRGS PRGO PRKR PRO PRTA PSN PTC PTCT PTON PUBG PVH QCOM QGEN QLGN QLYS QTRX RARE RCL RDNT REMY RFMD RGEN RH RIBT RIG RLAY RMBS RMD ROST RPTP RS RSP RTX RUN RVMD RYAAY SAGE SAN SBAC SBEA SCLX SCWX SD SE SEIC SELB SGEN SGH SHCR SHPG SI SIRI SITE SIVB SKX SLAB SLGN SMCI SMMR SMPL SNBR SNOW SOFI SOL SONO SOUN SPCE SPG SPLK SPOT SQ SQM SRDX SSYS ST STAG STAR STCN STLD STNG STOK STOR STX SUMO SWAV SWCH SWKS SYK SYMC SYNH SYRS T TAL TBBK TBC TCL TDOC TEAM TECK TEVA TFX TGT THC THMO TIDAL TIVO TISI TLRY TMO TMUS TNDM TNG TNK TORM TPIC TPRG TR TRC TRG TRIP TRMB TRN TROX TSCO TSE TSLA TSN TTD TTC TTWO TUSK TVTY TXN TXRH TYL U UAL UAN UBER UHAL ULTA UMC UNFI UNH UNIT UNM URBN USFD USI USNA UTHR V VAL VAR VBIV VCEL VCNX VCR VCSH VCTR VEC VECO VEL VEN VER VERU VFC VFH VHT VICR VIPS VIRC VRT VSH VSTM VTGN VTRS VTR VTWV VVNT VY W WAB WBA WDC WEC WELL WEN WERN WEX WFC WGO WHR WIA WMB WMT WNC WNR WPC WRB WST WTAI WTI WTW WU WY WYNN X XCEL XCUR XELA XOM XPER XPO XRAY XRO XRT XTL XYL YELL YETI YEXT YMM YNDX YRC YUM Z ZBH ZBRA ZGNX ZION ZLAT ZNH ZNTE ZOM ZRO ZSAN ZTO ZTS ZUO

Alnylam Pharmaceuticals Announces Changes to Board of Directors

businesswire.com
ALNY

23rd Annual MIT Sloan CFO Summit Concludes with Change-Led, Forward-Focused Insights

businesswire.com
ARM FDX HAS SHOP TPR ALNY XPO

New Post Hoc Analysis from the HELIOS-B Phase 3 Study Shows Vutrisiran Improved Measures of Heart Structure and Function in Patients with ATTR-CM

businesswire.com
ALNY